Eli Lilly & Co. and Novo Nordisk A\/S convinced a federal judge to throw out a pharmacy compounder\u2019s antitrust suit against the companies\u2019 blockbuster weight loss drugs, scoring a new win in one of the latest legal arguments over copycat GLP-1s.<\/p>\n
Strive Specialties Inc. failed to prove it suffers antitrust injuries because its compounded GLP-1 medications don\u2019t compete in the same market as branded versions, Senior Judge Micaela Alvarez of the US District Court for the Western District of Texas said in an order<\/a> entered Thursday.<\/p>\n \u201cStrive has failed to plausibly allege reasonable interchangeability or cross-elasticity of demand between its …<\/p>\n","protected":false},"excerpt":{"rendered":"Eli Lilly & Co. and Novo Nordisk A\/S convinced a federal judge to throw out a pharmacy compounder\u2019s…\n","protected":false},"author":2,"featured_media":141668,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[67785,15789,67784,272,64656,67783,360],"class_list":["post-141667","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-drug-approval-process","tag-drug-pricing","tag-exclusive-dealing","tag-novo-nordisk","tag-pharmaceutical-advertising","tag-pharmacy-care","tag-telehealth"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/117050722692242129","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/141667","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=141667"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/141667\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/141668"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=141667"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=141667"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=141667"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}